跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 136,471 条关于
“anti-PD-1/L1 therapy”
全部
136,471
临床试验
93,652
药物
14,246
机构
1,561
资讯
27,012
去年
BMS-986253 Fails to Improve Outcomes in Advanced Melanoma Post-PD-1/L1 Therapy
10个月前
Merck-Eisai Kidney Cancer Combination Shows Mixed Results in Phase 3 Trial
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Visugromab Plus Nivolumab Shows Promise in Anti-PD-1 Refractory Solid Tumors by Targeting GDF-15 Pathway
去年
Baili Tianheng's Novel Bispecific ADC Receives Fifth Breakthrough Therapy Designation for Small Cell Lung Cancer
去年
Pembrolizumab and Denileukin Diftitox Show Promise in Recurrent Solid Tumors
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Rise Therapeutics' R-5780 Receives FDA Clearance for Phase 1 Cancer Trial
去年
Optimizing Neoadjuvant Immunotherapy Strategies in Colorectal Cancer
9个月前
DART Trial Shows Combination Immunotherapy Effective in Rare Cancer Patients with Brain Metastases
第 1 页,共 2702 页
上一页
下一页